HIV Prevention Methods
The Latest
This Week in HIV Research: PrEP So White
May 21, 2020: PrEP demographics by health insurance claim data; pediatricians call for better PrEP formulations for teens; weight gain after switching from TDF to TAF; two-drug regimen efficacy when baseline viral load is high.
Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It
Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.
Investigational PrEP Injection, Dosed Every Other Month, Holds Up Against Daily PrEP in Phase 3 Study
The long-acting injectable drug cabotegravir proved non-inferior to daily oral TDF/FTC for MSM and transgender women.
CDC Issues New Guidance for Easier PrEP Access During COVID-19
Home HIV and STI testing is now being endorsed by the Centers for Disease Control and Prevention to start or continue pre-exposure prophylaxis (PrEP).
Increased HIV Testing and Treatment for Black Bisexual Men May Have Played a Role in HIV Drop in Black Women. But Has the Stigma Gone Away?
Researchers say the “bisexual bridge” theory creates stigma and biphobia.
COVID-19 Impacts Gay and Bisexual Men's Mental Health, Sexual Behavior, and Access to HIV/STI Services
This new study is the first to look at the impacts of the coronavirus pandemic on men who have sex with men.
This Week in HIV Research: There’s No Such Thing as Too Much Data
May 7, 2020: Epidemiological factors among transgender women; revised PrEP indication estimates for MSM; trends in HIV strain similarity between younger and older MSM; current hepatitis C epidemic among British MSM with HIV.
This Week in HIV Research: Special Considerations
April 30, 2020: Substance use relapse following opioid therapy for chronic pain; affect of cannabis on blood-brain barrier disruptions; PrEP considerations for adolescents; updated CDC contraceptive recommendations for women at risk for HIV.
Governor Brian Kemp’s COVID-19 Response Has Georgia On This HIV Doctor's Mind
Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.
This Week in HIV Research: The Fast-Acting Power of Integrase
April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.